April - June 2015, Volume 11, Issue 2

Antohe F

Mass Spectrometry Based Proteomics

Acta Endo (Buc) 2015, 11 (2): 139-142
doi: 10.4183/aeb.2015.139

Despite the progress of medical sciences of the past decades, many cellular disorders and pathological alterations related to different diseases have remained unsolved. The need for early recognition of the warning signs of particular diseases, cellular dysfunction and systemic inflammation translated by early biomarkers would be the real support for prevention, diagnosis and adequate strategies for treatment that can selectively target the cellular and molecular mediators. Lately the focus is directed toward the rapid transfer of proteomics research data generated with the top mass spectrometry technology to clinical practice for the benefit of human patients.

Keywords: proteomics, mass spectrometry, life sciences, personalized medicine.

Correspondence: Felicia Antohe, Ph.D., “N.Simionescu” Institute of Cellular Biology and Pathology - Proteomics, 8 BP Hasdeu Street, Bucharest, RO 050568, Romania, E-mail: felicia.antohe@icbp.ro